This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Vivian Xie
2 Jan 2023

2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0

Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.

As we welcome in a new year with new possibilities, CPHI Online is proud to bring you the 2023 Pharma Trends Outlook report in partnership with ACG World.

This Trend Report explores 12 trends predicted to shape the pharmaceutical landscape in 2023 and the implications they will have on all pharmaceutical players, including suppliers, research and development, manufacturing, and distribution. 

The pharmaceutical industry has witnessed a great many innovations and advancements in the last year. With 32 novel drug approvals to date, a bivalent COVID-19 vaccine, and the return of face-to-face events, the industry is primed to see the continuation of these positive developments. However, issues including supply chain disruptions, rising inflation, and global events such as the War in Ukraine have presented unprecedented challenges for the pharmaceutical industry, leaving all players feeling the pressures of these events. 

In this Trend Report, we cover trends such as Pharma 4.0 and the Data Revolution, sustainability trends, pharmaceutical start-up initiatives, cell and gene therapies, and more with expert insight from across the pharmaceutical value chain. As we enter a post-pandemic world and face new global challenges, the pharma industry must be applauded for its pursuit of new products, technologies and solutions which ultimately improve the lives of people worldwide. 

Register and download our full Trend Report to see what is in store for the pharmaceutical industry in 2023. 

Mentioned Companies
View company profile
Vivian Xie
Editor - Custom Content

Related News